Prescription Drug Pricing: Will Policy Fix What Patients Feel?
Prescription Drug Pricing: Will Policy Fix What Patients Feel?
The cost of prescription drugs in America continues to dominate headlines, and for good reason.
Recently, the White House announced plans to implement Most-Favored-Nation (MFN) pricing for prescription drugs. The goal is to ensure Americans pay no more than patients in other economically comparable countries for the same medications.
What is MFN Pricing?
MFN pricing ties the cost of drugs in the U.S. to the lowest price paid by other developed nations. It is an attempt to tackle the reality that Americans often pay two to four times more for brand-name medications compared to patients in Canada, the UK, or Australia.
The new executive order directs the Department of Health and Human Services to implement rules requiring drug manufacturers to align U.S. prices with the lowest available price among OECD nations. This could create significant shifts in how medications are priced and accessed domestically.
Will Policy Alone Solve High Costs?
While MFN pricing has the potential to lower costs for Medicare and some commercial plans, policy implementation can take time and may face legal or industry challenges.
In the meantime, employers and plan sponsors continue searching for practical ways to help patients afford medications today without waiting for legislative change.
International Sourcing as an Interim Solution
One approach already in place is international prescription sourcing through programs like ProCare Rx’s SavingEDGE Smart Delivery – International (SDI).
Here is what these programs do:
- Source maintenance medications from Tier 1 countries such as Canada, the UK, Australia, and New Zealand
- Offer FDA-approved brand medications at a fraction of U.S. costs
- Maintain safety standards and bioequivalence requirements
- Deliver medications directly to members’ homes with zero out-of-pocket costs
These programs help plan sponsors reduce spend while keeping patients on their necessary therapies, addressing the affordability challenge without waiting on policy reform.
Looking Ahead
The MFN executive order represents a major shift in U.S. drug pricing policy, aiming to bring prices in line with global standards. But even if fully enacted, these changes will take time.
In the meantime, solutions like international sourcing programs remain a practical bridge, ensuring patients can access life-sustaining medications safely and affordably.
Want to learn more about international prescription sourcing?
Visit
rxhelp.procarerx.com or call (855) 828-1484 to explore how it can integrate with your benefits strategy.
About ProCare Rx
ProCare Rx is a privately held, independent pharmacy benefit manager (PBM) that has empowered healthcare and self-insured organizations since 1988. We provide fully integrated, in-house solutions—including claims adjudication, clinical program design, pharmacy network access, cost containment, and data analytics—all supported in the U.S. Our flexible, transparent model serves self-insured employers, third-party administrators (TPA), brokers, health plans, health systems, managed care organizations (MCO), unions, workers’ compensation programs, Medicare, Medicaid, hospices, and other PBMs. With a proprietary technology platform, commitment to ethical operations, and a focus on lowest net cost, ProCare Rx delivers long-term value, clinical performance, and trusted pharmacy benefit partnerships.
Media Contact:
Marc Cohen, VP, Marketing and Sales
marketing@ProCareRx.com
